Literature DB >> 35284504

Safety analysis of COVID-19 vaccines in liver transplant recipients: a two-center study.

Rui Tang1, Chao Li1, Guangdong Wu1, Xuan Tong1, Lihan Yu1, Huayuan Hao1, Rui Liao2, Yucheng Hou1, Jun Li1, Wenping Zhao1, Tieyan Fan1, Leida Zhang2, Qian Lu1.   

Abstract

Entities:  

Year:  2022        PMID： 35284504      PMCID： PMC8847850          DOI： 10.21037/hbsn-21-392

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  6 in total

Review 1.  Safety of live vaccinations on immunosuppressive therapy in patients with immune-mediated inflammatory diseases, solid organ transplantation or after bone-marrow transplantation - A systematic review of randomized trials, observational studies and case reports.

Authors:  Evelina Croce; Christoph Hatz; Emile F Jonker; L G Visser; Veronika K Jaeger; Silja Bühler
Journal:  Vaccine       Date:  2017-02-03       Impact factor: 3.641

2.  Does vaccination in solid-organ transplant recipients result in adverse immunologic sequelae? A systematic review and meta-analysis.

Authors:  William R Mulley; Claire Dendle; Jonathan E H Ling; Simon R Knight
Journal:  J Heart Lung Transplant       Date:  2018-03-10       Impact factor: 10.247

3.  SARS-CoV-2 vaccination in patients with liver disease: responding to the next big question.

Authors:  Thomas Marjot; Gwilym J Webb; Alfred S Barritt; Pere Ginès; Ansgar W Lohse; Andrew M Moon; Elisa Pose; Palak Trivedi; Eleanor Barnes
Journal:  Lancet Gastroenterol Hepatol       Date:  2021-01-11

4.  Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients.

Authors:  Liane Rabinowich; Ayelet Grupper; Roni Baruch; Merav Ben-Yehoyada; Tami Halperin; Dan Turner; Eugene Katchman; Sharon Levi; Inbal Houri; Nir Lubezky; Oren Shibolet; Helena Katchman
Journal:  J Hepatol       Date:  2021-04-21       Impact factor: 25.083

5.  Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series.

Authors:  William A Werbel; Brian J Boyarsky; Michael T Ou; Allan B Massie; Aaron A R Tobian; Jacqueline M Garonzik-Wang; Dorry L Segev
Journal:  Ann Intern Med       Date:  2021-06-15       Impact factor: 25.391

6.  Liver injury after mRNA-based SARS-CoV-2 vaccination in a liver transplant recipient.

Authors:  Jérôme Dumortier
Journal:  Clin Res Hepatol Gastroenterol       Date:  2021-06-16       Impact factor: 2.947
  6 in total
  1 in total

1.  Humoral response to different SARS-CoV-2 vaccines in orthotopic liver transplant recipients.

Authors:  Liz Toapanta-Yanchapaxi; Erwin Chiquete; Esmeralda Ávila-Rojo; Silvia López-Yánez; Sonia Luna Del Villar Velasco; Sergio Rivera Monroy; Tomás López Gómez; Juan Bruno Andrés Aguilar; Denek Francisco Balcázar Antonio; Carlos Alcaraz-Fuerte; Magdalena García Baysa; José Luis López Jiménez; Ernesto Márquez-Guillén; Mario Vilatobá; Rodrigo Cruz-Martínez; Paulina Carpinteyro-Espin; Mariana Chávez-Villa; Ricardo Daniel Romero Morelos; Daniel Torres-Del Real; Luis F Uscanga-Domínguez; Mario García-Alanis; Ramiro Tapia Sosa; Maximiliano Servín-Rojas; Raymundo David Valdez-Echeverria; Ignacio García-Juárez
Journal:  Vaccine       Date:  2022-08-22       Impact factor: 4.169
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.